Study results and related evidence do not support use of HPV16 L1 DRH1 antibodies as a cancer screening test
Main Authors: | Tim Waterboer, Nicole Brenner, Jens P. Klussmann, Paul Brennan, Ulrike Wieland, Hilary A. Robbins |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-12-01
|
Series: | EBioMedicine |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352396420305193 |
Similar Items
-
Response to: “Study results and related evidence do not support use of HPV16 L1 DRH1 antibodies as a cancer screening test”
by: Thomas Weiland, et al.
Published: (2020-12-01) -
DRH1 – a novel blood-based HPV tumour marker
by: Thomas Weiland, et al.
Published: (2020-06-01) -
Unique Properties of Hepatocarcinogenesis-Resistant DRH Rat Hepatocytes Linked or Not Linked to the Drh1 Locus on Rat Chromosome 1
by: Norikazu Hashimoto, et al.
Published: (2011-01-01) -
Sensitivity and Specificity of Human Papillomavirus (HPV) 16 Early Antigen Serology for HPV-Driven Oropharyngeal Cancer: A Systematic Literature Review and Meta-Analysis
by: Julia Hibbert, et al.
Published: (2021-06-01) -
L’identité projetée des DRH
by: Ivan Sainsaulieu, et al.
Published: (2018-11-01)